• Publications
  • Influence
Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
TLDR
This narrative review, by specialists in the field of rheumatology, headache, and stroke, will outline the cause and pathophysiology, symptoms and signs, diagnosis, treatment, and prognosis of RCVS and areas of uncertainty. Expand
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
TLDR
The International Headache Classification Committee has worked out the more inclusive criteria for CM and MOH and it is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication over use. Expand
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
TLDR
Plasma exchange leads to functionally important neurological recovery in an important proportion of severely disabled patients with acute attacks of idiopathic inflammatory demyelinating disease, and was sustained on follow‐up. Expand
A self-administered screener for migraine in primary care
TLDR
The three-item ID Migraine™ migraine screener was found to be a valid and reliable screening instrument for migraine headaches and its ease of use and operating characteristics suggest that it could significantly improve migraine recognition in primary care. Expand
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study
TLDR
The results of this feasibility study offer promise and should prompt further controlled studies of occipital nerve stimulation (ONS) in CM. Expand
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled,
TLDR
Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, but with fewer associated adverse effects. Expand
Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
TLDR
These Guidelines are intended to assist in the design of well-controlled clinical trials of chronic migraine in adults, and do not apply to studies in children or adolescents. Expand
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults
TLDR
Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol are effective for migraine prevention and should be offered to patients with migraine to reduce migraine attack frequency and severity. Expand
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse Headache
TLDR
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—revision of criteria for 8.2 Medication-overuse headache is presented. Expand
...
1
2
3
4
5
...